XML 15 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 3,359 $ 3,526
Accounts receivable, net 3,186 4,528
Unbilled accounts receivable 224 406
Inventories 8,582 8,640
Prepaid expenses and other current assets 875 1,328
Total current assets 16,226 18,428
Equipment, furniture and leasehold improvements, net 8,921 8,553
Intangibles and other assets 269 326
Total assets 25,416 27,307
Current liabilities:    
Accounts payable 2,024 1,714
Accrued compensation 1,634 1,557
Revolving credit facility, net   3,808
Common stock warrant liability 1,497 784
Other accrued expenses 1,827 719
Deferred revenue 38 765
Other current liabilities 427 469
Total current liabilities 7,447 9,816
Commitments and contingencies (Note 9)
Shareholders' equity:    
Preferred stock, $.001 par value: authorized 10,000,000 shares: Series B Convertible Preferred stock, (liquidation preference of $5,659) stated value $1,000 per share, $.001 par value: 10,000 shares designated and 5,659 issued and outstanding as of December 31, 2018 and 2017
Common stock, $.001 par value: authorized 200,000,000 shares, issued 45,323,339 shares, outstanding 45,161,273 shares as of December 31, 2018 and issued 35,182,589 shares, outstanding 35,020,523 shares as of December 31, 2017 45 35
Additional paid-in capital 254,736 244,726
Accumulated deficit (236,312) (226,770)
Treasury stock, 162,066 shares as of December 31, 2018 and December 31, 2017 (500) (500)
Total shareholders' equity 17,969 17,491
Total liabilities and shareholders' equity $ 25,416 $ 27,307